跳至主要内容
临床试验/NCT03482167
NCT03482167已完成1 期

NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment

University of Delaware1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2019年3月20日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
64
试验地点
1
主要终点
Cognitive Scores at Baseline and Week 12

研究概览

简要总结

This study will provide insight into whether a nutritional supplement, nicotinamide riboside (NR), improves memory and brain blood flow in older adults with low memory abilities. Overall, this project has the potential to identify a novel, safe and cost-effective strategy for decreasing age-related memory loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Double-blind

入排标准

年龄范围
60 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Placebo

Placebo Comparator

placebo

干预措施: Placebo (Other)

Nicotinamide Riboside

Experimental

Niagen® (ChromaDex, Inc.) 500 mg, twice daily

干预措施: Niagen® (Drug)

结局指标

主要结局

Cognitive Scores at Baseline and Week 12

时间窗: baseline and 12 weeks

Primary outcome was a change from baseline in any domain of cognitive function. For all outcomes, a higher score indicates better cognitive function: 1. California Verbal Learning Test III (CVLT-III) Index Scores. Ability learn and recall a list of words over 5 trials and again after a 20 minute delay. Each Index Score has a mean of 100 and a standard deviation of 15 based on normative dataset (Range = 55 - 145). 2. Wechsler Memory Scale IV (WMS-IV) Raw Scores. * Logical Memory I \& II: Range = 0-50 * Logical Memory II Recognition: Range = 0-30 * Visual Reproduction I \& II: Range = 0-43 * Visual Reproduction II Recognition Score: Range = 0-7 3. NIH Toolbox Fluid Composite Score. Composite Score has a mean of 100 and a standard deviation of 15 based on normative dataset (Range = 55 - 145) - based on several tests of fluid and crystallized cognition (episodic memory, attention, working memory, processing speed, executive function and language abilities).

次要结局

  • Cerebrovascular Reactivity at Baseline and 12 Weeks(baseline and 12 weeks)
  • Total Brain Blood Flow at Baseline and 12 Weeks(baseline and 12 weeks)
  • Aortic Stiffness at Baseline and 12 Weeks(baseline and 12 weeks)
  • Blood Pressure at Baseline and 12 Weeks(baseline and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Martens

Assistant Professor

University of Delaware

研究点 (1)

Loading locations...

相似试验